Barcelona Institute for Global Health, University of Barcelona, Barcelona, Spain.
BMC Pediatr. 2021 Sep 8;21(Suppl 1):350. doi: 10.1186/s12887-021-02701-4.
We looked at existing recommendations and supporting evidence on the effectiveness of vitamin K given after birth in preventing the haemorrhagic disease of the newborn (HDN).We conducted a literature search up to the 10th of December 2019 by using key terms and manual search in selected sources. We summarized the recommendations and the strength of the recommendation when and as reported by the authors. We summarized the main findings of systematic reviews with the certainty of the evidence as reported.All newborns should receive vitamin K prophylaxis, as it has been proven that oral and intramuscular prophylactic vitamin K given after birth are effective for preventing classical HDN. There are no randomized trials looking at the efficacy of vitamin K supplement on late HDN. There are no randomized trials comparing the oral and intramuscular route of administration of prophylactic vitamin K in newborns. From older trials and surveillance data, it seems that there is no significant difference between the intramuscular and the oral regimens for preventing classical and late HDN, provided that the oral regimen is duly completed. Evidence assessing vitamin K prophylaxis in preterm infants is scarce.
我们研究了现有的关于新生儿出生后给予维生素 K 以预防新生儿出血性疾病(HDN)的有效性的建议和支持证据。我们使用关键词和选定来源的手动搜索,进行了截至 2019 年 12 月 10 日的文献检索。我们总结了作者报告的建议和推荐强度。我们按照报告的证据确定性总结了系统评价的主要结果。所有新生儿均应接受维生素 K 预防,因为已证明口服和肌肉内预防性维生素 K 可有效预防经典 HDN。目前尚无研究维生素 K 补充剂对晚期 HDN 疗效的随机试验。也没有比较新生儿预防性维生素 K 口服和肌肉内给药途径的随机试验。从较旧的试验和监测数据来看,只要口服方案得到妥善完成,肌肉内和口服方案在预防经典和晚期 HDN 方面似乎没有显著差异。评估早产儿维生素 K 预防的证据很少。